Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Pathology|October 21, 2010
The specificity of immunophenotypic alterations in blasts in nonacute myeloid disordersAlexandra Harrington, Horatiu Olteanu, Steven Kroft
Cases Journal|December 1, 2009
Sperm in peritoneal fluid from a man with ascites: a case reportHoratiu Olteanu, Alexandra Harrington, Steven H Kroft
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|November 25, 2010
Multifocal vulvar smooth muscle tumor with an unusual intravascular growth pattern and multiple local recurrences in a 10-year-old child: a diagnostic dilemmaAlexandra Harrington, Emily Bell, Mariko Suchi, et al.
Journal of Brown Hospital Medicine|April 7, 2025
A Triple Threat: Acute Systemic Lupus Erythematosus Unveiled with Hemophagocytic Lymphohistiocytosis and Toxic Epidermal NecrolysisCharmi Shah, Lisa Cotter, Elliot Yu, et al.
Frontiers in Oncology|February 21, 2022
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of RelapseBinod Dhakal, Shruti Sharma, Mustafa Balcioglu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2020
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing ThemSaurabh Chhabra, Aniko Szabo, Chad Glisch, et al.
Leukemia|February 15, 2025
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemiaSameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, et al.
Haematologica|April 4, 2024
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemiaGuru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, et al.
Blood Advances|August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapiesEdward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.
Blood Advances|March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditionsAmy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Pageof 1